BRR OpCo’s Provectus Biopharmaceuticals PVCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-40,000
Closed -$2K – 173
2018
Q4
$2K Hold
40,000
– – ﹤0.01% 108
2018
Q3
$3K Hold
40,000
– – ﹤0.01% 112
2018
Q2
$3K Hold
40,000
– – ﹤0.01% 111
2018
Q1
$2K Hold
40,000
– – ﹤0.01% 107
2017
Q4
$3K Buy
+40,000
New +$3K ﹤0.01% 102

Other funds holding PVCT

BRR OpCo's PVCT Position: Q1 2019 in Review

BRR OpCo sold out of Provectus Biopharmaceuticals (PVCT) in Q1 2019, closing a stake of 40,000 shares — an estimated $2K sold.

BRR OpCo first reported a position in PVCT in Q4 2017 and held it in 5 quarters. The position peaked at $3K in Q3 2018. 4 funds tracked by Wall St. Rank hold PVCT as of Q1 2019.

  • BRR OpCo reported no remaining Provectus Biopharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • BRR OpCo sold 40,000 Provectus Biopharmaceuticals shares in Q1 2019, an estimated $2K.
  • BRR OpCo first reported a position in Provectus Biopharmaceuticals in Q4 2017 and held it in 5 quarters.
  • BRR OpCo's Provectus Biopharmaceuticals position peaked at $3K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Provectus Biopharmaceuticals as of Q1 2019.

Based on BRR OpCo's 13F filing for Q1 2019, filed 26 Apr 2019.